Diagnostic Test
AssigneeIsis Innovation Limited
InventorAjit Lalvani
Life of this patent
Estimating the term…
Loading patent…
AssigneeIsis Innovation Limited
InventorAjit Lalvani
Estimating the term…
The invention provides a method of diagnosing Mycobacterium tuberculosis infection in a human, or of determining whether a human has been exposed to Mycobacterium tuberculosis, comprising: (i) contacting T-cells from said human with one or more of (a) a peptide having the sequence shown in SEQ ID NO: 1; (b) a peptide having or comprising the sequence of at least 8 consecutive amino acids of the sequence shown in SEQ ID NO: 1; or (c) a peptide having or comprising a sequence which is capable of binding to a T-cell receptor which recognises a peptide as defined in (a) or (b); and (ii) determining whether any of the said T-cells recognise said peptide, wherein steps (i) and (ii) are optionally carried out in vitro.
A method of diagnosing Mycobacterium tuberculosis infection in a human, or
A method of increasing the sensitivity of a diagnostic test for diagnosing Mycobacterium tuberculosis infection in a human, wherein said diagnostic test comprises contacting T cells from said human with a Mycobacterium tuberculosis antigen which is not Rv3879c, said method additionally comprising
(canceled)
A method of ascertaining the stage of a Mycobacterium tuberculosis infection in a human comprising determining whether there is a differential T cell response to different antigens in the human.
Dependencies are inferred from the claim text.